+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Effects of the 5-HT2A receptor antagonist, MDL 100,907 and the 5-HT2C receptor antagonist, SB 206553, on lordosis responding of female rats



Effects of the 5-HT2A receptor antagonist, MDL 100,907 and the 5-HT2C receptor antagonist, SB 206553, on lordosis responding of female rats



Society for Neuroscience Abstracts 24(1-2): 1924




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 031187067

Download citation: RISBibTeXText


Related references

Differential effects of the 5-HT2A receptor antagonist MDL100,907 and the 5-HT2C receptor antagonist SB242,084 on cocaine induced locomotor activity, cocaine self-administration and cocaine induced reinstatement of responding. Society for Neuroscience Abstracts 27(1): 1176, 2001

Is the apparent antipsychotic action of the 5-HT2A receptor antagonist M100907 counteracted by concomitant 5-HT2C receptor antagonist treatment?. Society for Neuroscience Abstracts 24(1-2): 1369, 1998

Effects of the 5-HT2C receptor agonist Ro60-0175 and the 5-HT2A receptor antagonist M100907 on nicotine self-administration and reinstatement. Neuropharmacology 62(7): 2288-2298, 2012

Facilitatory effects of WAY-100635, a 5-HT1A receptor antagonist, on lordosis in female rats. Neuroscience Letters 371(2-3): 147-151, 2004

(+)-cis-4,5,7a,8,9,10,11,11a-Octahydro-7H-10-methylindolo[1,7-bc][2,6]- naphthyridine: A 5-Ht2C/2B Receptor Antagonist with Low 5-Ht2A Receptor Affinity. Journal of Medicinal Chemistry 38(1): 28-33, 1995

(+)-cis-4,5,7a,8,9,10,11,11a-octahydro-7H-10-methylindolo[1,7- bc][2,6]-naphthyridine: a 5-HT2C/2B receptor antagonist with low 5-HT2A receptor affinity. Journal of Medicinal Chemistry 38(1): 28-33, 1995

Effects of noncompetitive nmda receptor antagonist on lordosis and motor behaviors in female rats. Society for Neuroscience Abstracts 17(1-2): 498, 1991

5-HT2c receptor antagonists, but not a 5-HT2A or 5-HT2B receptor antagonist, attenuate haloperidol-induced catalepsy in rat. British Journal of Pharmacology 125(PROC SUPPL ): 65P, 1998

Anxiety-like effects induced by acute fluoxetine, sertraline or m-CPP treatment are reversed by pretreatment with the 5-HT2C receptor antagonist SB-242084 but not the 5-HT1A receptor antagonist WAY-100635. International Journal of Neuropsychopharmacology 4(4): 399-408, 2002

The effects of antipsychotics with 5-HT2C receptor affinity in behavioral assays selective for 5-HT2C receptor antagonist properties of compounds. European Journal of Pharmacology 388(1): 57-67, Jan 24, 2000

Effects of NRA0045, a novel potent antagonist at dopamine D4, 5-HT2A, and alpha1 adrenaline receptors, and NRA0160, a selective D4 receptor antagonist, on phencyclidine-induced behavior and glutamate release in rats. Psychopharmacology 169(3-4): 247-256, 2003

(1R, 3S)-(-)-trans-PAT: a novel full-efficacy serotonin 5-HT2C receptor agonist with 5-HT2A and 5-HT2B receptor inverse agonist/antagonist activity. European Journal of Pharmacology 615(1-3): 1-9, 2009

Co-administration of 5-HT6 receptor antagonists with clozapine, risperidone, and a 5-HT2A receptor antagonist: effects on prepulse inhibition in rats. Psychopharmacology 231(1): 269-281, 2014

Effects of the 5-HT2C/2B antagonist SB 206553 on hyperactivity induced by cocaine. Neuropsychopharmacology 20(6): 556-564, 1999

Strain-dependent effects of diazepam and the 5-HT2B/2C receptor antagonist SB 206553 in spontaneously hypertensive and Lewis rats tested in the elevated plus-maze. Brazilian Journal of Medical and Biological Research 34(5): 675-682, 2001